These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 487550)

  • 21. Mitral valve prolapse syndrome: neuro-endocrinological aspects.
    Boudoulas H; Wooley CF
    Herz; 1988 Aug; 13(4):249-58. PubMed ID: 2844639
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Magnesium deficiency in the pathogenesis of mitral valve prolapse.
    Galland LD; Baker SM; McLellan RK
    Magnesium; 1986; 5(3-4):165-74. PubMed ID: 3014234
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Disorders of the autonomic nervous system in mitral prolapse: facts and opinions].
    Puddu P; Bertaccini B; Bugiardini R
    G Ital Cardiol; 1987 Jul; 17(7):609-12. PubMed ID: 3315810
    [No Abstract]   [Full Text] [Related]  

  • 24. Autonomic dysfunction in women with mitral valve prolapse syndrome.
    Gaffney FA; Karlsson ES; Campbell W; Schutte JE; Nixon JV; Willerson JT; Blomqvist CG
    Circulation; 1979 May; 59(5):894-901. PubMed ID: 428102
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Orthostatic hypotension, catecholamines, and alpha-adrenergic receptors in mitral valve prolapse.
    Schatz IJ; Ramanathan S; Villagomez R; MacLean C
    West J Med; 1990 Jan; 152(1):37-40. PubMed ID: 2155518
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mitral valve prolapse.
    Devereux RB
    Prim Care; 1985 Mar; 12(1):39-54. PubMed ID: 3846308
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Systolic time intervals in mitral valve prolapse syndrome].
    Yazaki N; Niwayama H; Onishi M; Sunami Y; Nishimoto Y; Masuda Y; Inagaki Y
    J Cardiol Suppl; 1989; 21():75-80, discussion 81-3. PubMed ID: 2778645
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Mitral valve prolapse: two-dimensional echocardiographic screening in apparently healthy students].
    Fujii K; Ishida Y; Tanouchi J; Ishihara K; Matsuyama T; Nishioka H; Uematsu M; Ozaki H; Tani A; Kitabatake A
    J Cardiol Suppl; 1988; 18():9-17, discussion 18-9. PubMed ID: 3267187
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mitral valve prolapse syndrome: etiology and symptomatology.
    Cornell LV
    Nurse Pract; 1985 Apr; 10(4):25-6, 29, 34. PubMed ID: 3991085
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pandora's box of autonomic ills found in some heart patients.
    González ER
    JAMA; 1981 Jan; 245(2):107-8. PubMed ID: 7452822
    [No Abstract]   [Full Text] [Related]  

  • 31. [Ventricular function in mitral valve prolapse: effects of beta adrenergic blockers with and without intrinsic sympathomimetic activity].
    Marin-Neto JA; Mattar Júnior L; Maciel BC; Gallo Júnior L; Iazigi N; Ferro D
    Arq Bras Cardiol; 1989 May; 52(5):247-52. PubMed ID: 2690783
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Arrhythmia in mitral valve prolapse].
    Madry K
    Wiad Lek; 1981 Jun; 34(12):997-1000. PubMed ID: 7029917
    [No Abstract]   [Full Text] [Related]  

  • 33. [Prevalence of tricuspid and aortic valve prolapse in patients with mitral valve prolapse].
    Ribeiro CL; Ginefra P; Albanesi Filho FM; Christiani LA; Quaresma JC; Gomes Filho JB
    Arq Bras Cardiol; 1989 Nov; 53(5):251-5. PubMed ID: 2629684
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exercise left ventricular performance in patients with mitral valve prolapse.
    Iskandrian AS
    Herz; 1988 Aug; 13(4):243-8. PubMed ID: 3169678
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [QT/QS2 index in patients with arterial hypertension, mitral valve prolapse and hyperthyroidism].
    Purzycki Z; Nowicki M; Reguła J; Bieniaszewski L; Zaborowski K; Zdrojewski T
    Pol Tyg Lek; 1992 Jul 6-13; 47(27-28):576-8. PubMed ID: 1488330
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Arrhythmia in patients with mitral valve prolapse syndrome and the status of the sympathetic nervous system].
    Sniezek-Maciejewska M; Piwowarska W; Mroczek-Czernecka D; Mazurek S; Kmita A; Jaśkiewicz J; Dubiel JP
    Pol Tyg Lek; 1990 Mar 5-12; 45(10-11):203-5. PubMed ID: 1699213
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Late potentials in patients with prolapse of the mitral valve].
    Bertoni PD; Cozzi G; Guidali P; Canziani R
    Minerva Cardioangiol; 1991 Nov; 39(11):433-6. PubMed ID: 1808539
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autonomic function in mitral valve prolapse.
    Lancet; 1987 Oct; 2(8562):773-4. PubMed ID: 2888989
    [No Abstract]   [Full Text] [Related]  

  • 39. Mitral valve prolapse: left ventricular hemodynamics in patients with chest pain, dyspnea or both.
    Vavuranakis M; Kolibash AJ; Wooley CF; Boudoulas H
    J Heart Valve Dis; 1993 Sep; 2(5):544-9. PubMed ID: 8269165
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Erythrocyte magnesium in symptomatic patients with primary mitral valve prolapse: relationship to symptoms, mitral leaflet thickness, joint hypermobility and autonomic regulation.
    Coghlan HC; Natello G
    Magnes Trace Elem; 1991-1992; 10(2-4):205-14. PubMed ID: 1844553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.